CVS Shares Fall Despite Earnings, Revenue Beat

Trade CVS Shares Your Capital Is At Risk
Analyst Team
Updated: 9 Feb 2022

Key points:

CVS Health Corp (NYSE: CVS) announced earnings per share of $1.98 before the bell on Wednesday, with revenue coming in at $76.6 billion.


The numbers reported were against an anticipated EPS of $1.82 and revenue of $75.63 billion.

Revenue rose 10.1% compared to the prior year, which the company said was driven by growth across all segments. Furthermore, Covid-19 vaccine demand and at-home Covid test demand raised overall store sales.

Also Read: Best Healthcare Stocks to Buy Right Now

In reaction to the report, CVS's share price has declined 2.73% to $107.80.

“We're engaging millions of customers across our businesses and in our community health destinations, becoming an even bigger part of their everyday health. That's clearly reflected in our performance, but more importantly in our potential.” said Karen S. Lynch, CVS Health President, and CEO.

Looking ahead, the company expects adjusted EPS guidance to be in the range of $8.10 to $8.30 for 2022.

CVS shares have fallen ahead of the opening bell despite the positive report. However, they have risen over 50% in the last 12 months.

CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage . 68 % of retail investor accounts lose money when trading CFDs with this provider . You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money .